Subcutaneous Vascular Access Port With Expandable Implant Base

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing vascular access ports cause harm to local tissues and decrease target blood vessel functionality due to repeated needle pricking and are invasive, requiring improvements for less traumatic and simpler implantation, especially for chronic diabetes, dialysis, or chemotherapy patients.

Innovation Solution

A vascular access port system with a port body and a port body extension that can be subcutaneously changed from a delivery configuration to a deployed configuration, forming a unified structure with increased volume and base area, allowing for atraumatic tissue separation and fixation, facilitated by a port delivery apparatus.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a traditional vascular access port is implanted using surgical methods, then the port can be securely implanted in the subcutaneous tissue, but the procedure is invasive and causes tissue trauma

Engineering Contradiction:
Improvesecure implantationVSAvoidtissue trauma
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The port device is divided into two separate components: a port body and a port body extension. The extension is implanted first through a minimally invasive percutaneous approach, creating a subcutaneous pocket and establishing a tract. The port body is then delivered through this pre-formed tract and connected to the extension, avoiding the need for large surgical incisions and reducing tissue trauma while ensuring secure implantation.

Inventive Principle:
Principle #1Segmentation

2Duration of action of moving object

If repeated needle pricking is performed through the port for fluid delivery, then fluid administration can be repeated over time, but harm accumulates to local tissues and blood vessel functionality decreases

Engineering Contradiction:
Improverepeated fluid administrationVSAvoidtissue harm accumulation
Core Design Contradiction:
Duration of action of moving objectVSObject-affected harmful factors

Solution Approach 1:

The port device serves as an intermediary structure with a septum that allows repeated needle punctures. The septum is designed to seal around the needle after each puncture, maintaining the integrity of the port cavity and preventing tissue fluid leakage. This intermediary mechanism enables repeated fluid administrations over extended periods while minimizing cumulative tissue damage compared to direct repeated venous punctures.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Stability of the object's composition

If a port body extension is added to the vascular access port system, then the port can be deployed with increased volume and base area for improved stability, but the device complexity increases

Engineering Contradiction:
Improveport stabilityVSAvoiddevice structure
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The port system is segmented into a port body and a port body extension that are implanted separately through different approaches. The extension is inserted first through a small percutaneous incision and positioned in the subcutaneous tissue to provide a stable base. The port body is then delivered through a separate tract and connected to the extension, allowing each component to be optimized for its specific function while contributing to overall system stability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The port body and port body extension are designed to connect together to form a unified port structure. The connection mechanism integrates the two components, combining the stability-providing extension with the functional port body to create a single stable implant that benefits from the increased volume and base area of the combined structure.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS12589231B2Subcutaneously changeable vascular access port
Publication Date: 2026.03.31 PORTAL ACCESS INC
  • US12589231B2 patent drawing
  • US12589231B2 patent drawing
  • US12589231B2 patent drawing

AI summary

Disclosed is a vascular access port selectively changeable subcutaneously from delivery configuration to deployed configuration. The vascular access port includes a port body and a port body extension being partly or wholly disengaged in the delivery configuration, and fixedly connected to form a unified structure of the vascular access port, greater in volume than the port body, in the deployed configuration. Methods and kits for deploying the vascular access port in a body of a subject are also disclosed.